SAHPRA

    The South African Health Products Regulatory Authority has sounded the alarm over counterfeit diabetes medication. There is a rise in particularly GLP-1 products like Ozempic, being sold through unauthorised channels. SAHPRA's Madimetja Mashishi says these fake medications pose serious health risks as they lack quality checks. He urges the public to buy only registered products: